Abstract
Determination of coagulation Factor XIII (F XIII)-related parameters in 21 patients with Henoch-Schönlein purpura documented a significant decrease of F XIII activity as well as of the F XIII-related antigenic determinants. Subgroup analysis with regard to the clinical symptoms showed an even further decrease of these parameters in patients with gastrointestinal complications. Stimulated by these findings a substitution therapy with a F XIII concentrate was initiated in those patients whose F XIII activity in plasma remained low and who developed severe abdominal pain accompanied by persisting gastrointestinal bleeding. This therapeutic approach not only corrected the laboratory data, but more important led to a cessation of pain and bleeding. A rapid decrease of F XIII levels after transfusion below 40 U/ml was indicative of relapse of abdominal symptoms, while increasing values were associated with the recovery of the patients. In conclusion: F XIII activity determinations appear to have a predictive value in patients with Henoch-Schönlein purpura, and the administration of F XIII concentrates may contribute to the improvement of gastrointestinal complications.
Similar content being viewed by others
Abbreviations
- F XIII:
-
Factor XIII
- SHP:
-
Henoch-Schönlein purpura
- XIII-act:
-
Factor XIII activity
- MCA:
-
monochloroacetic acid
- XIII-A:
-
Factor XIII subunit A antigen
- XIII-S:
-
Factor XIII subunit S antigen
- F VIII R:AG:
-
Factor VIII related antigen
- FDP:
-
Fibrin degradation products
- F VIII:C:
-
Factor VIII coagulant activity
References
Bohn H (1972) Comparative studies of the fibrin-stabilizing factors from human plasma, platelets and placenta. Ann N Y Acad Sci 202:256–272
Egbring R, Schmidt W, Fuchs G, Havemann K (1977) Demonstration of granulocytic protease in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood 49:219–231
Fukui H, Yoshiya H, Katagiri S, Yoshioka A, Mikami S, Okuda T, Niida T, Daida K, Yoshida K (1974) Congenital factor XIII (fibrin stabilizing factor) deficiency; report of three cases. Jpn J Clin Hematol 15:191–200
Hardisty RM, MacPherson JC, Ingram GIC (1962) A one-stage factor VIII (antihemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh 7:215–229
Henriksson P, Hedner U, Nilsson IM, Nilsson PG (1975) Generalized proteolysis in a young woman with Weber-Christian disease (modular non-suppurative panniculitis). Scand J Haematol 14: 355–360
Henriksson P, hedner U, Nilsson IM (1977) Factor XIII (fibrin stabilizing factor) in Henoch-Schönlein's purpura. Acta Pediatr Scand 66:273–277
Henriksson P, Nilsson IM, Oklsson K, Stenberg P (1980) Granulocyte elastase activation and degradation of factor XIII. Thromb Res 18:343–351
Kataoka S, Haneda M, Morita K, Koyama K (1975) Studies on determination of plasma fibrinogen using TG-meter. Jpn J Clin Path 23:466–470
Laki K, Lorand L (1948) On the solubility of fibrin clots. Science 108:280
Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45–52
Loewy AG, Dunatham K, Kriel R, Wolfinger HL Jr (1960) Fibrinase 1. Purification of substrate and enzyme. J Biol Chem 236: 2625–2633
Nilsson IM, Bergentz SE, Wiklander O, Hedner U (1975) Erosive hemorrhagic gastroduodenitis with fibrinolysis and low factor XIII. Ann Surg 182:677–682
Schmidt W, Egbring R, Havemann K (1975) Effect of elastase-like and chymotrypsin-like natural proteases from human granulocytes on isolated clotting factors. Thromb Res 6:315–326
Schwartz ML, Pizzo SV, Hill RL, McKee PA (1973) Human factor XIII from plasma and platelets. J Biol Chem 248:1395–1407
Tani K (1979) Studies on factor XIII in children with various renal diseases. I. Plasma factor XIII activity, factor XIII subunit-A antigen and factor XIII subunit S antigen. J Nara Med Ass 30:262–270
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamitsuji, H., Tani, K., Yasui, M. et al. Activity of blood coagulation Factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Eur J Pediatr 146, 519–523 (1987). https://doi.org/10.1007/BF00441608
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441608